No Data
No Data
Even With A 33% Surge, Cautious Investors Are Not Rewarding Outset Medical, Inc.'s (NASDAQ:OM) Performance Completely
Painful Week for Individual Investors Invested in Outset Medical, Inc. (NASDAQ:OM) After 18% Drop, Institutions Also Suffered Losses
TD Cowen Maintains Outset Medical(OM.US) With Buy Rating, Cuts Target Price to $15
Positive Outlook for Outset Medical: Buy Rating and $15 Price Target Amid Share Adjustments and Market Trends
Stryker, Boston Scientific Down as New Tariffs Impact Medtech Industry
Wall Street Analysts Predict an 188.63% Upside in Outset Medical (OM): Here's What You Should Know